Exhibit 99.1
Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
NEW YORK (April 27, 2026) – WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global
leader in science-backed weight management, today announced that it intends to utilize up to $40 million in cash to prepay and reduce the principal amount of its outstanding term loan.
The prepayment will be comprised of the following two components:
| |
|
|
$25 million to $30 million in aggregate principal amount of prepayment in cash of the annual cash sweep
amount, which is due to be paid on June 24, 2026; and |
| |
|
|
a voluntary solicitation for prepayment by the Company to utilize up to $10 million in cash to prepay its
term loan at a discount, which solicitation is expected to commence on Monday, April 27, 2026 and close on April 30, 2026. |
In
connection with today’s announcement, Weight Watchers reaffirmed its first quarter 2026 end of period subscriber estimates and full year 2026 financial guidance as previously provided on March 16, 2026, in conjunction with the
Company’s fourth quarter and full year 2025 results. Following these announcements and based on its full year 2026 financial guidance, the Company expects to generate cash through the remainder of the year following first quarter cash usage
due to peak season marketing.
“Today’s announcements reflect the progress we have made over the last year to strengthen our liquidity
position and deleverage our balance sheet,” said Felicia DellaFortuna, Weight Watchers CFO and member of the Company’s Interim Office of the Chief Executive. “As we continue to execute against our strategic priorities, we remain
focused on maintaining a strengthened capital structure, supported by durable cash generation, to fund continued investments in our integrated weight health ecosystem and drive sustainable, profitable growth.”
About Weight Watchers
Weight Watchers is the global
leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With
more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes
U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its
members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape
crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward
that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.
Forward-Looking Statements
This press release contains
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements,
including without limitation statements regarding the Company’s intention to utilize up to $40 million to prepay and reduce the principal amount of its outstanding term loan and the Company’s full-year financial guidance and
outlook. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,”